Finance

Beta
Lists
Q1 2027 earnings • released • EPS beat +11.18% • Revenue beat +0.66%
See results
HQY:NASDAQ
Healthequity Inc
$87.99
-2.79%
(-2.53) 1D
$87.99
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HQY...
Open
$91.52
High
$95.00
Low
$86.05
Mkt. cap
7.38B
Avg. vol.
908.16K
Volume
2.83M
P/E ratio
35.77
52-wk high
$116.65
52-wk low
$72.76
EPS
$2.46
Beta
0.19
Shares outstanding
83.83M
No. of employees
3K
Open
$91.52
High
$95.00
Low
$86.05
Mkt. cap
7.38B
Avg. vol.
908.16K
Volume
2.83M
P/E ratio
35.77
52-wk high
$116.65
52-wk low
$72.76
EPS
$2.46
Beta
0.19
Shares outstanding
83.83M
No. of employees
3K
News stories
From sources across the web
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOJon Kessler | Scott Cutler
Employees2.81K
FoundedJan 1, 2002
HeadquartersDraper, Utah, United States
SectorHealth care provider
Websitehealthequity.com
Last report
May 28, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$1.24 / $1.12
+11.18%beat
Revenue / Est. (USD)
354.64M / 352.30M
+0.66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
325.84M
322.16M
334.59M
354.64M
Cost of goods sold
93.24M
94.10M
106.44M
98.33M
Cost of revenue
93.24M
94.10M
106.44M
-
Research and development expenses
64.80M
65.92M
70.35M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.91M
55.29M
58.45M
-
Operating expense
141.72M
148.21M
155.75M
152.25M
Total operating expenses
234.96M
242.31M
262.19M
250.58M
Operating income
90.88M
79.85M
72.40M
104.07M
Other non operating income
27.00K
22.00K
329.00K
-
EBT including unusual items
78.05M
67.53M
60.90M
-
EBT excluding unusual items
79.31M
68.69M
62.22M
93.53M
Income tax expense
18.19M
15.84M
11.16M
23.00M
Effective tax rate
23.31%
23.46%
18.32%
-
Other operating expenses
-
-
-
-
Net income
59.85M
51.69M
49.74M
69.42M
Net profit margin
18.37%
16.05%
14.87%
-
Earnings per share
1.08
1.01
0.95
1.24
Interest and investment income
3.36M
2.86M
2.77M
-
Interest expense
-14.96M
-14.05M
-13.27M
-12.59M
Net interest expenses
-11.59M
-11.18M
-10.50M
-12.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
129.33M
118.63M
111.08M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer